Origen de la red de primer grado Yasumitsu Shimada.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Yasumitsu Shimada a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ITOCHU CORPORATION | Food Distributors | Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst | |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Investment Managers | Consultant / Advisor | |
| Keio University | College/University | Undergraduate Degree | |
| University of London | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Wales (Bangor) | College/University | Masters Business Admin | |
| GLAND PHARMA LIMITED | Pharmaceuticals: Major | Chairman Chairman | |
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Tokyo University of Pharmacy & Life Science | College/University | Graduate Degree | |
Eddingpharm (Cayman), Inc.
 Eddingpharm (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Eddingpharm (Cayman) Inc. provides specialty pharmaceuticals marketing services. It focuses on medical nutrition and oncology therapeutic areas and creates a commercialization platform for pharmaceutical products. The company was founded by Xin Ni and Jiang Yao in 2001, and is headquartered in Hong Kong. | Pharmaceuticals: Major | Chief Operating Officer | |
| Amsino Medical | Chief Executive Officer | ||
Xi'an Libang Pharmaceutical Co. Ltd.
 Xi'an Libang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Xi'an Libang Pharmaceutical Co. Ltd. is a private company that develops, produces, and distributes pharmaceutical products. The company is based in Xi'an, China. | Pharmaceuticals: Major | Director/Board Member | |
| Searle Yakuhin KK | Corporate Officer/Principal | ||
Baxter (China) Investment Co. Ltd.
 Baxter (China) Investment Co. Ltd. Financial ConglomeratesFinance Part of Baxter International, Inc., Baxter (China) Investment Co. Ltd. provides investment services. The company is based in Shanghai, China. | Financial Conglomerates | Corporate Officer/Principal | |
| BizPro International LLC | Corporate Officer/Principal | ||
LTL Pharma Co., Ltd.
 LTL Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology LTL Pharma Co., Ltd. is a pharmaceutical company founded in 2016 and based in Tokyo, Japan. The Japanese company specializes in long-term products and aims to provide reliable and effective products to patients. The company's website includes a product list page that is limited to medical professionals. LTL Pharma actively seeks business alliances with other companies both domestically and overseas. The company's top management greetings are also available on their website. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Shenzhen Tailai Biotechnology Co., Ltd.
 Shenzhen Tailai Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shenzhen Tailai Biotechnology Co., Ltd. is a Chinese company that specializes in the research and development of cancer screening products and services. The company is based in Shenzhen, China. and has subsidiaries in China. Yiu Kwan Lau has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chief Executive Officer | |
| MEDSCI HEALTHCARE HOLDINGS LIMITED | Medical/Nursing Services | Director/Board Member |
Estadísticas
Internacional
| Japón | 7 |
| Estados Unidos | 6 |
| China | 5 |
| Reino Unido | 3 |
| India | 2 |
Sectorial
| Health Technology | 8 |
| Consumer Services | 5 |
| Finance | 4 |
| Distribution Services | 2 |
| Commercial Services | 2 |
Operativa
| Corporate Officer/Principal | 10 |
| Director/Board Member | 7 |
| Undergraduate Degree | 4 |
| Chairman | 4 |
| Chief Executive Officer | 3 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Yiu Kwan Lau | 12 |
| Yoshihiro Arai | 5 |
| Koji Shinozaki | 4 |
| Stanley Lau | 3 |
| Jiro Mizukawa | 2 |
| Toshio Miyashita | 1 |
| Yasuaki Manabe | 1 |
- Bolsa de valores
- Insiders
- Yasumitsu Shimada
- Conexiones Empresas
